← Back to Search

Digital Exposure Treatment for Youth with Chronic Pain

N/A

Recruiting

Led By Lauren E Harrison, PhD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have moderate to high pain interference (PROMIS Pain Interference ≥ 61)

Have diagnosis of chronic musculoskeletal pain (>3months)

Must not have

Significant medical or psychiatric problems that would interfere with treatment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline through 3-month follow-up (up to 22 weeks)

Awards & highlights

No Placebo-Only Group

Summary

This trial will systematically develop and evaluate a new exposure treatment for youth with chronic pain, using a method that allows for rigorous evaluation at the individual level.

Who is the study for?

This trial is for young people aged 10-17 with chronic musculoskeletal pain lasting more than 3 months. They must be able to read English and have access to a digital device with internet. Participants should experience moderate to high pain interference in their daily lives. Those with significant cognitive impairments or serious medical/psychiatric issues that could affect treatment are not eligible.

What is being tested?

The study is testing a new digital program called iGET Living, designed as graded exposure treatment for managing chronic pain in youth. The effectiveness of this online intervention will be evaluated using an individual-focused experimental design over a period of six weeks, followed by outcome assessments three months post-treatment.

What are the potential side effects?

Since the intervention involves digitally delivered therapy without medication, traditional side effects are not expected. However, participants may experience discomfort or emotional distress when facing situations related to their chronic pain during the exposure exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My pain significantly affects my daily activities.

Select...

I have had muscle or joint pain for more than 3 months.

Select...

I am between 10 and 17 years old.

Select...

I have had muscle or joint pain for more than 3 months.

Select...

My pain significantly affects my daily activities.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have major health or mental issues affecting treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline through 3-month follow-up (up to 22 weeks)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline through 3-month follow-up (up to 22 weeks)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline through 3-month follow-up (up to 22 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Assessment of Acceptability of Treatment Content and Digital Delivery Questionnaire - Likert Scale (Aim 1 and Aim 2)

Assessment of Acceptability of Treatment Content and Digital Delivery Questionnaire - Participant Responses (Aim 1 and Aim 2)

Expectations for Treatment (Aim 2)

+3 more

Secondary study objectives

Child Fear of Pain (Aim 2)

Child Pain Acceptance (Aim 2)

Child Pain Catastrophizing (Aim 2)

+4 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Graded Exposure InterventionExperimental Treatment1 Intervention

For Aim 2, adolescents with chronic pain will be enrolled in a single-arm feasibility trial examining acceptability, feasibility, and preliminary effectiveness of a novel, digitally delivered, graded exposure treatment.

0 / 6Eligibility criteria met